Skip to main content

Peer Review reports

From: Salvage PRRT with 177 Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Original Submission
29 Mar 2019 Submitted Original manuscript
18 Jun 2019 Author responded Author comments - Simon Rudisile
14 May 2019 Reviewed Reviewer Report - Chiara Maria Grana
12 Jun 2019 Reviewed Reviewer Report - Giulia Polverari
Resubmission - Version 2
18 Jun 2019 Submitted Manuscript version 2
25 Jul 2019 Author responded Author comments - Simon Rudisile
11 Jul 2019 Reviewed Reviewer Report - Chiara Maria Grana
26 Jun 2019 Reviewed Reviewer Report - Giulia Polverari
Resubmission - Version 3
25 Jul 2019 Submitted Manuscript version 3
29 Jul 2019 Author responded Author comments - Simon Rudisile
Resubmission - Version 4
29 Jul 2019 Submitted Manuscript version 4
Publishing
30 Jul 2019 Editorially accepted
8 Aug 2019 Article published 10.1186/s12885-019-6000-y

You can find further information about peer review here.

Back to article page
\